Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen: May 5, 2005

Premium

Qiagen this week launched the GeneGlobe database, which houses "matching solutions" for RNAi and gene-expression analysis "covering the entire human, mouse, and rat genomes," the company said. "More than 70,000" predesigned siRNAs and validated, ready-to-use SYBR Green-based qRT-PCR assays can be sourced from the searchable database at www.qiagen.com/GeneGlobe, the company added.

Qiagen also launched its QuantiTect reverse-transcription kit, which requires "only 20 minutes" to synthesize first-strand cDNA and eliminate genomic DNA contamination, the company said this week in a statement. Genomic DNA is removed from starting RNA samples through a 2-minute buffer incubation, after which the treated RNA is directly reverse transcribed, the company said.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.